Navigation Links
UC Davis researchers visualize formation of a new synapse
Date:6/17/2009

(SACRAMENTO, Calif.) A protein called neuroligin that is implicated in some forms of autism is critical to the construction of a working synapse, locking neurons together like "molecular Velcro," a study lead by a team of UC Davis researchers has found.

Published online in the June issue of the journal Neural Development, the study is accompanied by groundbreaking images that are the first to show two neurons coming together using neuroligin to construct a new synapse.

"Previous research has suggested that neuroligin is critical for the formation and stabilization of synapses," said Kimberley McAllister, an associate professor of neurology in the UC Davis School of Medicine and a researcher at the UC Davis Center for Neuroscience. "Our work suggests that neuroligin is one of the first molecules to be recruited to new synapses and that it also acts as Velcro to strengthen those new connections."

Neuroligin is a member of a family of four protein molecules that bind to another family of proteins, the β-neurexins, across synapses. During the past decade, scientists have observed that neuroligin is critical for synapse formation and function, but it is only recently that a link between the two synapse-forming molecules and autism has been recognized, McAllister said.

Lead study author and UC Davis postdoctoral fellow Stephanie Barrow said that researchers had hypothesized that neuroligin could facilitate the recruitment of other proteins important in building synapses, but no one had been able to directly visualize the process. That's because synapses are less than 1 micron wide 100 times narrower than a strand of human hair. To view the process, the researchers cultured neurons taken from newly born rats and flourescently labled the proteins neuroligin, PSD-95 and NMDA which are critical to synapse formation.

"We are the first to observe that neuroligin zips around dendrites (the branched projections of neurons) before synapses form and can accumulate very soon after contact between cells," Barrow said.

Barrow described what the team was able to visualize:

"Axons of one neuron grow toward the dendrites of neighboring neurons. As they do so, finger-like structures called filopodia extend and retract rapidly from the tip of the axons and eventually make a stable contact with the dendrite. We can then see neuroligin accumulate at these new contact sites very rapidly, possibly stabilizing adhesion between the two cells. After a few minutes, more neuroligin accumulates at this contact site, bringing NMDA receptors in with it, which is then followed by a much slower recruitment of PSD-95."

The images that accompany the study show that, indeed, the two synaptic receptor proteins, PSD-95 and NMDA, are independently recruited to the site of synapse formation once the connections are locked in place by neuroligin.

"Synapses are basically specialized sites of cell adhesion that are initially formed during development of the nervous system. Formation of viable synapses is crucial for establishing neuronal circuits that underlie behavior and cognition," said study senior author Philip Washbourne, a UC Davis postdoctoral fellow when the study was initiated and now an assistant professor of biology at the University of Oregon.

McAllister and Barrow are continuing to capture images of the dynamics of other important molecules during synapse formation. Their goal is to create a virtual cinematic representation that includes many of the molecules that play important roles in the formation of a normal, working synapse.

"Many people think that improper synapse formation leads to the symptoms of autism," McAllister said. "This research will allow us to learn more about how synapses form to better understand what aspects of synapse formation might be altered in the disorder."


'/>"/>

Contact: Phyllis Brown
phyllis.brown@ucdmc.ucdavis.edu
916-734-9023
University of California - Davis - Health System
Source:Eurekalert

Related biology news :

1. UC Davis begins $2.8 million in studies of agricultural nitrogens impacts
2. UC Davis bioengineer receives Hartwell Foundation grant to address skull fusion disorder of infants
3. UC Davis launches One Health care for wild mountain gorillas and human neighbors
4. UC Davis researchers identify a protein that may help breast cancer spread, beat cancer drugs
5. UC Davis bench-to-bedside research: Promising treatment in clinical trials
6. UC Davis research shows that newly discovered drug reduces heart enlargement
7. UC Davis researchers find molecule that targets brain tumors
8. UC Davis discovery offers hope for treating kidney cancer
9. UC Davis team refines cancer treatments to reduce potential nerve damage
10. UC Davis researchers exploring gene therapy to fight AIDS
11. UC Davis researchers discover Achilles heel in pancreatic cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
Breaking Biology Technology: